Nicolas M. Van Mieghem, MD, PhD, FESC, FACC

Professor and Clinical Director of Interventional cardiology
Thoraxcenter
Rotterdam, Zuid-Holland, Netherlands

Medical degree and cardiology degree at the Catholic University of Leuven, Belgium. Fellowships in interventional cardiology in Belgium, Lenox Hill Hospital, New York and EMC, Rotterdam. Degree of PhD based upon his research in transcatheter valve therapies. Senior staff member interventional cardiology in the Thoraxcenter, Erasmus MC in February 2010. Clinical directior of Interventional Cardiology since 2014. Full professor of Interventional Cardiology at the Erasmus University Medical Center since September 1 2019. Published and co-authored over 500 scientific papers in peer-reviewed journals. Principle or co- investigator in multiple ongoing international trials . FESC and FACC.

Presentation(s):

• CARDIOTUBE INTERVIEW: CEP the next step which device which studies

  Saturday, February 25, 2023
  2:00 PM – 2:10 PM ET

  Disclosure information not submitted.

• IVUS CHIP

  Saturday, February 25, 2023
  4:38 PM – 4:55 PM ET

  Disclosure(s): Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)

• Panel Discussion | Who Should get MCS for High-Risk PCI and with Which Device?

  Sunday, February 26, 2023
  9:41 AM – 10:00 AM ET

  Disclosure(s): Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)

• Suture Based Versus Collagen Plugs for Closures of Large Bores

  Sunday, February 26, 2023
  11:08 AM – 11:16 AM ET

  Disclosure(s): Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)

• Panel Discussion | Vascular Access and Closure Related Issues

  Sunday, February 26, 2023
  11:32 AM – 11:55 AM ET

  Disclosure(s): Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)

• Protection Devices for Stroke Prevention for All if Feasible

  Monday, February 27, 2023
  1:46 PM – 1:54 PM ET

  Disclosure(s): Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)

• Moderated Discussion: Embolic Protection for All TAVR Patients - The Pros and Cons

  Monday, February 27, 2023
  2:10 PM – 2:25 PM ET

  Disclosure(s): Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)

• Moderate Aortic Stenosis the Next Frontier for TAVI

  Monday, February 27, 2023
  5:12 PM – 5:20 PM ET

  Disclosure(s): Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)

• Panel Discussion: Practical and Hot Topics

  Monday, February 27, 2023
  5:20 PM – 5:45 PM ET

  Disclosure(s): Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)

• Stroke After TAVR: To Protect or Not to Protect?

  Monday, February 27, 2023
  7:06 PM – 7:21 PM ET

  Disclosure(s): Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)

• Roundtable Discussion and Conclusion

  Monday, February 27, 2023
  7:21 PM – 7:30 PM ET

  Disclosure(s): Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)

• LATE-BREAKING TRIALS | SESSION FOUR

  Tuesday, February 28, 2023
  8:00 AM – 9:00 AM ET

  Disclosure(s): Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)

• Panel Discussion | Second- and Third-Generation Aortic Valve Systems not Approved in the US Yet

  Tuesday, February 28, 2023
  10:18 AM – 10:30 AM ET

  Disclosure(s): Abbott Inc: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Amgen: Consultant/Advisory Board (Ongoing); Anteris: Consultant/Advisory Board (Ongoing); AstraZeneca: Grant/Research Support (Ongoing); Biotronik: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); BostonScientific: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); Daiichi Sankyo, Inc.: Consultant/Advisory Board (Ongoing), Grant/Research Support (Ongoing); Edwards Lifesciences: Grant/Research Support (Ongoing); JenaValve Technology Inc: Consultant/Advisory Board (Ongoing); Medtronic Inc: Advisory Committee/Board Member (Ongoing), Grant/Research Support (Ongoing); PulseCath BV: Consultant/Advisory Board (Ongoing)